To investigate whether inhibition of the Klf5/Cox2 axis reinforces the efficiency of immune checkpoint blockade and considering the high expression of Klf5 in EMT6 and CT26 cell lines, ablation of cancer cell-intrinsic Klf5 in the CT26 colon and EMT6 breast cancer models was first applied to test the hypothesis. This evidence concerns the gene PTGS2 and cancer.